ISSN2320-2882
Impact Factor9.17
UGC ParametersAligned
Low Cost₹1501 / $59
CrossRefDOI
ESTD2013
Peer ReviewTransparent
AccessOpen
Submission: Always Open

Paper Title

Formulation And Characterization Of Folate Conjugated PEG Spacer-based Nanoparticle For The Effective Targeting Against Breast Cancer Cell Line

Authors

Sailesh Chandra Biswal , Dr. Arun Patel

Keywords

solid lipid nanoparticles; paclitaxel; nanocarriers; breast cancer

Abstract

Conventional chemotherapy is frequently hampered by a lack of tumor selectivity, resulting in systemic toxicity and a narrow therapeutic window. To address these limitations, this study reports the design, synthesis, and evaluation of actively targeted solid lipid nanoparticles (SLNs) for the enhanced delivery of paclitaxel (PTX). A series of PTX-loaded SLNs were developed and surface-functionalized with folic acid (FA) as a targeting ligand. The formulations included SLNs with FA conjugated directly to the surface (SLNFA) and SLNs with FA attached via polyethylene glycol (PEG) spacers of two different molecular weights, 1000 Da (SLNP1FA) and 4000 Da (SLNP4FA). Physicochemical characterization revealed that surface modification progressively increased particle size while maintaining a narrow distribution, and significantly enhanced drug entrapment. The SLNP4FA formulation demonstrated the highest drug entrapment efficiency at 58.22% and exhibited the most sustained in vitro drug release profile over 48 hours. The therapeutic efficacy of the nanocarriers was assessed against folate receptor (FR)-positive MCF-7 human breast cancer cells. All folate-targeted formulations showed superior cytotoxicity compared to free PTX and non-targeted SLNs. Crucially, the efficacy was dependent on the PEG spacer length, with SLNP4FA exhibiting the highest potency. This formulation achieved an IC50 value of 331.29 nM, representing a 48.39% reduction in the IC50 compared to free PTX. These findings demonstrate that optimizing the PEG spacer length is a critical strategy for overcoming steric hindrance and maximizing receptor-mediated endocytosis. The FA-PEG (4000)-SLN architecture represents a highly effective and promising platform for the targeted delivery of chemotherapeutic agents to solid tumors.

How To Cite

Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.

IJCRT — journal style
"Formulation And Characterization Of Folate Conjugated PEG Spacer-based Nanoparticle For The Effective Targeting Against Breast Cancer Cell Line", IJCRT - International Journal of Creative Research Thoughts (www.ijcrt.org), ISSN:2320-2882, Vol.13, Issue 9, page no.e898-e921, September 2025, Available :https://ijcrt.org/papers/IJCRT2509562.pdf
APA — 7th edition
Biswal, S. C., & Patel, A. (2025). Formulation And Characterization Of Folate Conjugated PEG Spacer-based Nanoparticle For The Effective Targeting Against Breast Cancer Cell Line. International Journal of Creative Research Thoughts, 13(9), e898-e921. https://ijcrt.org/viewpaperforall.php?paper=IJCRT2509562
MLA — 9th edition
Biswal, Sailesh Chandra, and Arun Patel. "Formulation And Characterization Of Folate Conjugated PEG Spacer-based Nanoparticle For The Effective Targeting Against Breast Cancer Cell Line." International Journal of Creative Research Thoughts, vol. 13, no. 9, 2025, pp. e898-e921, https://ijcrt.org/viewpaperforall.php?paper=IJCRT2509562.
Chicago — 17th, bibliography
Biswal, Sailesh Chandra, and Arun Patel. "Formulation And Characterization Of Folate Conjugated PEG Spacer-based Nanoparticle For The Effective Targeting Against Breast Cancer Cell Line." International Journal of Creative Research Thoughts 13, no. 9 (2025): e898-e921. https://ijcrt.org/viewpaperforall.php?paper=IJCRT2509562.
Harvard — author–date
Biswal, S.C. and Patel, A. (2025) 'Formulation And Characterization Of Folate Conjugated PEG Spacer-based Nanoparticle For The Effective Targeting Against Breast Cancer Cell Line', International Journal of Creative Research Thoughts, 13(9), pp. e898-e921. Available at: https://ijcrt.org/viewpaperforall.php?paper=IJCRT2509562
IEEE — numbered reference
S. C. Biswal and A. Patel, "Formulation And Characterization Of Folate Conjugated PEG Spacer-based Nanoparticle For The Effective Targeting Against Breast Cancer Cell Line," IJCRT, vol. 13, no. 9, pp. e898-e921, Sep. 2025.
Vancouver — biomedical
Biswal SC, Patel A. Formulation And Characterization Of Folate Conjugated PEG Spacer-based Nanoparticle For The Effective Targeting Against Breast Cancer Cell Line. IJCRT. 2025 Sep;13(9):e898-e921.
AMA — 11th edition
Biswal SC, Patel A. Formulation And Characterization Of Folate Conjugated PEG Spacer-based Nanoparticle For The Effective Targeting Against Breast Cancer Cell Line. IJCRT. 2025;13(9):e898-e921. Accessed at https://ijcrt.org/viewpaperforall.php?paper=IJCRT2509562
BibTeX — Zotero, Mendeley, LaTeX
@article{IJCRT2509562, author = {Sailesh Chandra Biswal and Arun Patel}, title = {Formulation And Characterization Of Folate Conjugated PEG Spacer-based Nanoparticle For The Effective Targeting Against Breast Cancer Cell Line}, journal = {International Journal of Creative Research Thoughts}, volume = {13}, number = {9}, pages = {e898-e921}, year = {2025}, month = {September}, issn = {2320-2882}, url = {https://ijcrt.org/viewpaperforall.php?paper=IJCRT2509562} }
RIS — EndNote, RefWorks
TY - JOUR AU - Biswal, Sailesh Chandra AU - Patel, Arun TI - Formulation And Characterization Of Folate Conjugated PEG Spacer-based Nanoparticle For The Effective Targeting Against Breast Cancer Cell Line T2 - International Journal of Creative Research Thoughts JA - IJCRT VL - 13 IS - 9 PY - 2025 SN - 2320-2882 UR - https://ijcrt.org/viewpaperforall.php?paper=IJCRT2509562 SP - e898-e921 ER -

Issue

Volume 13 Issue 9, September-2025
Pages : e898-e921

Article Information

Pages
e898-e921
Published
September 2025
Registration ID
IJCRT_294006
Published Paper ID
IJCRT2509562
Research Area
Pharmacy All
Author Type
Indian Author
Location
Jabalpur, Madhya Pradesh, India
Licence
CC BY 4.0 · Open Access
ISSN & Impact Factor
2320-2882 · IF 9.17
Downloads
219

Summarise this Paper with AI

Opens your assistant with a prepared prompt. AI summaries can be incomplete or wrong — read the full paper before citing it.

Share This Article

Author Services

Certificates, printed copies and official reports for this paper

Published authors can request a hard copy of their certificate or of the printed journal, and obtain the transparent peer review and plagiarism reports for this article — each issued against this paper’s registration record.

Registration ID IJCRT_294006

About Publisher

International Journal of Creative Research Thoughts Published by IJCRT Publication
2320-2882 ISSN
9.17 Impact Factor
2013 ESTD Year
Open Access
Impact Factor 9.17, calculated from Google Scholar citation data — see how it is worked out.
An international scholarly open access journal: peer-reviewed, refereed, multidisciplinary, monthly and multilingual, with Crossref DOI registration, rich metadata and a citation generator. Verified indexing & discovery records.
IJCRT is a Transparent, Peer-Reviewed, Open Access Journal (Refereed Journal). Following the discontinuation of UGC and UGC-CARE journal listing, IJCRT is aligned with UGC’s Suggested Parameters for Choosing Peer-Reviewed Journals. UGC Public Notice

Licence

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
 Disclaimer: The content, data and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses or consequences arising from its use.

Declarations

Funding

No external funding was received for this study.

Conflict of Interest

The authors declare that they have no conflict of interest.

Acknowledgements

The authors would like to thank the reviewers and the editorial board of International Journal of Creative Research Thoughts for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.

About the Journal
9.17Impact Factor UGC AlignedSuggested Parameters TransparentPeer Review
Open AccessNo Paywall
CrossrefDOI Available
Monthly12 Issues / Year
Since 2013Established
2320-2882ISSN

Article Impact

47Views
36Downloads
83Total reads
Sep 2025Published
Published · 388 days ago Today · last read today
83 TOTAL
Views 47Downloads 36
77%
Readers who went on to take the PDF
Abstract views47
PDF downloads36

1.9 views and 1.4 downloads per day over 25 days counted.

Counts exclude identified crawler traffic and repeat hits from the same reader within 30 minutes. Downloads reached directly through a search engine or an existing citation link are not included, so the figure is a conservative count of activity through this site. Full statistics

Discovery & Indexing

Find this paper on search engines and scholarly indexes, and check the journal’s verified records.

Find this paperSearch
  • Google ScholarExact-title search, with citing articles once indexed.Search
  • CrossrefMetadata search across all Crossref records.Search
  • Semantic ScholarAI-powered literature search.Search
  • BASEBielefeld Academic Search Engine — open-access harvester.Search
  • ResearchGateResearch network publication search.Search

“Search” opens a live search for this paper; “Verified” opens a journal record checked on the Indexing & Discovery page. Third-party services index at their own discretion, often several weeks after publication.

Research & Publication Timeline
Indexed, Abstracted & Author Benefits
Just ₹1501
Publish in a UGC CARE Approved Journal | Low Cost ₹1501 Indian Author | 🌐 $59 USD International
CrossRef DOI Google Scholar Transparent Review ISSN Registered 1–2 Days UGC CARE
Submit Paper →